骨転移における骨質芽細胞:腫瘍の微小環境と治療標的の重要な役割

Lingxiao Jin¹, Zhenxuan Shao¹, Zhaoming Ye¹

¹Orthopedic Oncology Services, Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China; Orthopedic Research Institute, Zhejiang University, Hangzhou 310009, China; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou 310009, China; Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou 310009, China.

Biochimica et biophysica acta. Reviews on cancer

|August 31, 2025

まとめ

オステオブラストは,腫瘍細胞の引き寄せ,休眠状態,増殖に影響を与えることで,骨転移に重要な役割を果たします. オステオブラストの相互作用をターゲットにすることで骨癌治療の新たな戦略が生まれます

科学分野:

腫瘍学
細胞生物学
癌の転移

背景:

オステオブラストは骨代謝の重要な調節体であり,骨腫瘍の微小環境 (TME) で重要な役割を果たしていることがますます認識されています.
骨転移の進行を促進する彼らの特定の役割は完全に理解されていません.
既存の研究は,骨質芽細胞が骨格腫瘍の発達の様々な段階に有意に影響することを示唆しています.

研究の目的:

骨転移のオーケストラ化におけるオステオブラストの多面的な役割を解明する.
オステオブラストと腫瘍細胞の間の段階特有の相互作用を詳細に説明する.
オステオブラストと腫瘍細胞のコミュニケーションを標的とした治療戦略を探求する.

主な方法:

骨転移におけるオステオブラスト機能に関する最近の研究のレビュー
オステオブラストと腫瘍細胞の相互作用に関与する分子信号伝達経路の分析 (例えば,CXCL12/CXCR4,TGFβ2,BMP7,N-カデリン).
TME内の免疫細胞活動とマクロファージの偏化に対するオステオブラストの影響の検討.

主要な成果:

オステオブラストは腫瘍細胞を惹きつけ,ニッチを再構成し,早期のコロニー化と休眠期における治療抵抗性を促進する.
代謝結合とmTORの活性化によって転移を促します
オステオブラストは,抗腫瘍免疫を抑制し,免疫回避を促進することによってTMEを調節する.

結論:

オステオブラストは,直接的および間接的なメタスタシスの進行を制御する中心部である.
腫瘍に由来する信号は腫瘍の成長を支援するために骨質細胞を再プログラムします
オステオブラスト媒介の経路を標的とした治療は骨癌の有望な治療法です

キーワード:

骨転移マイクロ環境オステオブラスト

さらに関連する動画

07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.7K

06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.2K

関連する概念動画

02:17

The Tumor Microenvironment

6.8K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

6.8K

01:31

Osteoclasts in Bone Remodeling

3.2K

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

3.2K

02:30

Metastasis

5.7K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

5.7K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

02:38

Mitogens and the Cell Cycle

6.6K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...